cancer treatment

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

cancer treatment
May 28, 2025, 05:38 | Drugs
Sorafenib (Nexavar): What patients need to know?
Sorafenib is a targeted cancer treatment taken as a tablet. It has been approved by…
May 27, 2025, 21:28 | Blog
Tingting Zhang: Join to discuss patient partnering in managing chronic toxicities of cancer treatment
Tingting Zhang, Patient Advocate, shared a post by MASCC, adding: "Join us to discuss patient…
May 23, 2025, 10:02 | Drugs
Eribulin (Halaven): What patients need to know?
Eribulin is a chemotherapy drug primarily used for treating metastatic breast cancer and liposarcoma, a…
May 23, 2025, 08:08 | Drugs
Eribulin (Halaven): Uses in Cancer, Side effects, Dosage, Expectations, and more
Eribulin is an anticancer chemotherapy agent classified as a microtubule dynamics inhibitor and structurally related…
May 20, 2025, 09:22 | Drugs
Pluvicto (177Lu-PSMA-617): What patients need to know?
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used for treating advanced…
May 19, 2025, 18:28 | Blog
Cancer treatment has evolved dramatically - FDA Oncology
FDA Oncology shared on X: "Cancer treatment has evolved dramatically! Then: Surgery and radiation were…
May 18, 2025, 11:49 | Blog
How Cancer Treatment Has Transformed with Modern Therapies - FDA Oncology
FDA Oncology shared a post on X: "Cancer treatment has evolved dramatically! Then, Surgery and…
May 18, 2025, 05:14 | Drugs
Pluvicto (177Lu-PSMA-617): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioligand therapy used to treat advanced…
May 16, 2025, 13:21 | Oncolibrary
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved retifanlimab-dlwr (Zynyz, Incyte…
May 15, 2025, 01:25 | Blog
Kashyap Patel: Emerging Health Concern - The Intersection of COVID-19 and Cancer Diagnoses
Kashyap Patel, Medical Director of the International Oncology Network, Past President at Community Oncology Alliance,…
May 14, 2025, 18:42 | Oncolibrary
FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer
On May 14, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval for…
May 14, 2025, 14:44 | Science
Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer
Wafik El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director…
May 12, 2025, 07:42 | Blog
American Association for Cancer Research (AACR): Advancing the Frontiers of Cancer Science Since 1907
In 1907, a small group of eleven visionary scientists gathered in Washington, D.C. to take…
May 11, 2025, 13:51 | Oncolibrary
FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results
On May 8, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to…
May 9, 2025, 12:42 | Drugs
Penpulimab: What patients need to know?
Penpulimab, also known by its generic name penpulimab-kcqx, is a newly FDA-approved immunotherapy for certain…
May 9, 2025, 09:15 | Drugs
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
​Penpulimab is a novel humanized monoclonal antibody that targets PD-1 (programmed death-1), a key immune…
May 8, 2025, 18:12 | Opinion
Erman Akkus highlights new platinum derivatives Aurkine 16 and 18 for cancer treatment
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "New platinum…
May 7, 2025, 08:18 | Science
Luis Diaz: The Inspiring Story of Kelly Spill highlights the Transformative Potential of Advancements in Cancer Treatment
Luis Diaz, Head of the Division of Solid Tumor Oncology within the Department of Medicine at…
May 6, 2025, 10:13 | Cancer Types
Thyroid Cancer: Symptoms, Causes, Stages, Diagnosis, and Treatment
Thyroid cancer is a type of cancer that begins in the thyroid gland, a small,…
May 5, 2025, 13:03 | Science
Multicenter Analysis of High-Dose Chemotherapy Regimens For The Treatment of Patients With Refractory or Recurrent GCTs
ESMO Open shared a post on X: "Multicenter analysis of high-dose chemotherapy regimens for the…
May 5, 2025, 10:26 | Science
Jasmin Hundal: Can a WhatsApp-based remote exercise program improve the quality of life for older adults with cancer?
Jasmin Hundal, Hematology Oncology Fellow at Cleveland Clinic, shared an article on LinkedIn: "Can a WhatsApp-based…
May 5, 2025, 10:03 | Science
Top Clinical Trials at ESTRO 2025: Organ Preservation and Quality of life after Total Neoadjuvant Therapy for LA Rectal Cancer
Fresh from the stage at ESTRO 2025 - Gani Cihan presented the the impact of…
May 5, 2025, 09:34 | Science
Elvina Almuradova: From Dose-Finding to Dose-Optimization in Early-Phase Oncology Clinical Trials
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article…
May 1, 2025, 08:58 | Drugs
Vimseltinib (Romvimza): Uses in Cancer, Side effects, Dosage, Expectations, and more
Vimseltinib is an oral kinase inhibitor that selectively targets the colony-stimulating factor 1 receptor (CSF1R).…
May 1, 2025, 06:15 | Blog
Congratulations to our newest MASCC-Designated Centers of Excellence in Supportive Care in Cancer - MASCC
The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn: "Congratulations…
Apr 30, 2025, 13:49 | Drugs
Cabozantinib: What patients need to know?
Cabozantinib is a targeted therapy used to treat various types of cancer. This oral medication…
Apr 30, 2025, 07:31 | Drugs
Cabozantinib: Uses in Cancer, Side effects, Dosage, Expectation, and more
Cabozantinib is an oral tyrosine kinase inhibitor used to treat various cancers. It targets multiple…
Apr 25, 2025, 15:26 | Blog
SIOP Europe and CCI-E joint position for the revision of the EU pharmaceutical legislation
SIOP Europe shared a post on Facebook: "Unlocking new possibilities with what we already have.…
Apr 25, 2025, 14:11 | Blog
Cognitive Impairment and Accelerated Brain Aging: The Insult of Cancer and Cancer Treatment on the Brain - IOWG
Integrative Oncology Working Group, shared a post on LinkedIn: "Sunday April 27, 2025 1PM EST.…
Apr 25, 2025, 09:57 | Blog
What to Expect at the AACR Annual Meeting 2025: Key Highlights and Must-Attend Sessions​
The AACR Annual Meeting 2025, taking place from April 25–30 at McCormick Place Convention Center…
Apr 25, 2025, 05:55 | Drugs
Durvalumab (Imfinzi): What patients need to know?
Durvalumab is a cancer immunotherapy designed to help the immune system recognize and attack cancer…
Apr 24, 2025, 13:53 | Drugs
Durvalumab (Imfinzi): Uses in Cancer, Side effects, Dosage, Expectations and More
​Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that targets the programmed death-ligand…
Apr 23, 2025, 22:49 | Blog
Supporting Families in Pediatric Oncology in South Africa - Childhood Cancer International
Childhood Cancer International shared a post on LinkedIn: "In South Africa, CHOC Childhood Cancer Foundation…
Apr 23, 2025, 10:33 | Blog
Herbert Loong: It was a real pleasure meeting so many lung cancer friends
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on LinkedIn:…
Apr 23, 2025, 10:15 | Drugs
Binimetinib (Mektovi): What patients need to know?
Binimetinib, sold under the brand name Mektovi, is an FDA-approved oral medication used to treat…
Apr 22, 2025, 15:25 | Drugs
Binimetinib (Mektovi): Uses in Cancer, Side effects, Dosage, Expectations, and more
Binimetinib is an oral targeted cancer therapy that belongs to a class of drugs known…
Apr 22, 2025, 02:45 | Blog
Daniel Flora: This Is What the Ideal Cancer Treatment Looks Like
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 21, 2025, 23:52 | Blog
Carmen Monge-Montero: Rasika Bombatkar on a Surprising Side Effect of Cancer Treatment
Carmen Monge-Montero, Researcher and patient advocate at Youth Cancer Europe, shared a post on LinkedIn:…
Apr 20, 2025, 11:06 | Drugs
Loqtorzi (Toripalimab): What patients need to know?
Toripalimab (Loqtorzi) is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by…
Apr 19, 2025, 16:23 | Blog
Elvina Almuradova: Olaparib improved ORR and PFS in BRCA-mutated PSR ovarian cancer, but no OS benefit
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Apr 19, 2025, 13:12 | Drugs
Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Toripalimab is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by blocking…
Apr 19, 2025, 01:00 | Blog
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival
Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post…
Apr 17, 2025, 17:02 | Blog
Daniel Flora: New targeted therapy combined with chemotherapy for metastatic colon cancer
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 17, 2025, 07:35 | Drugs
Selpercatinib (Retevmo): What patients need to know?
Selpercatinib (Retevmo) is a targeted therapy to treat cancers driven by RET gene alterations. This…
Apr 16, 2025, 17:55 | Blog
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Amol Akhade, Senior Medical and Hemato-Oncologist based in Mumbai, India, shared a post on LinkedIn:…
Apr 16, 2025, 09:40 | Immune Oncology
What Are the Signs That Immunotherapy Is Working?
Immunotherapy has revolutionized cancer treatment by activating the body’s immune system to recognize and destroy…
Apr 15, 2025, 17:59 | Blog
New guidance for managing gastrointestinal symptoms from cancer treatment - Digestive Cancers Europe
Digestive Cancers Europe shared a post on LinkedIn: "Managing Gastrointestinal symptoms from Cancer Treatment: New…
Apr 15, 2025, 15:10 | Blog
Samantha Siegel: Onco-Primary Approach to Symptoms in Survivorship
Samantha Siegel, Director of Cancer Survivorship at The Permanente Medical Group, shared a post on…
Apr 15, 2025, 09:30 | Blog
Online guidance for sports after cancer treatment - Antoni van Leeuwenhoek
Antoni van Leeuwenhoek shared a post on LinkedIn: "Online guidance for sports after cancer treatment…
Apr 15, 2025, 01:57 | Blog
Proposed cuts to medical research funding threaten to delay progress in clinical trials - Fight Colorectal Cancer
Fight Colorectal Cancer shared a post on LinkedIn: "Proposed cuts to medical research funding threaten…
Apr 14, 2025, 16:49 | Blog
Antonio Giordano’s Novel Work Offers New Hope in the Fight Against Cancer - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Dr. Antonio Giordano’s novel work on…
Apr 12, 2025, 15:58 | Oncolibrary
FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial
April 11, 2025 — The U.S. Food and Drug Administration (FDA) has approved the combination…
Apr 12, 2025, 11:00 | Immune Oncology
Can Immunotherapy Make Cancer Worse? When Immunotherapy Stops Working
Immunotherapy is a form of cancer treatment that stimulates the body’s immune system to recognize…
Apr 11, 2025, 02:26 | Drugs
Enhertu (Trastuzumab deruxtecan): What patients need to know?
Cancer treatment has advanced significantly, and one of the most promising breakthroughs is Trastuzumab deruxtecan.…
Apr 10, 2025, 14:00 | Drugs
Trastuzumab deruxtecan (Enhertu): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Trastuzumab deruxtecan (Enhertu) is a smart drug that targets HER2-positive cancer cells, delivering a potent…
Apr 10, 2025, 11:00 | Blog
Mary Nassiri’s experience of running a marathon during her cancer treatment - ICR
The Institute of Cancer Research shared a post on LinkedIn: " 'During my cancer treatment,…
Apr 9, 2025, 15:57 | Cancer Types
Ocular Melanoma: Symptoms, Causes, Stages, Diagnosis and Treatment
Ocular melanoma is a rare but serious type of cancer that arises from melanocytes within…
Apr 6, 2025, 13:44 | Celebrities
Cynthia Nixon's Breast Cancer Journey: How She Went Against, Survived, and More
Cynthia Nixon is an accomplished American actress, activist, and politician best known for her role…
Apr 4, 2025, 13:43 | Drugs
Sotorasib (Lumakras): What Patients need to know?
Sotorasib (brand name: Lumakras) is an innovative targeted therapy that has changed the landscape of…
Apr 4, 2025, 11:24 | Blog
Adriana Kahn and Philippos Costa contribute to advancing cancer treatment at Yale Cancer Center
Yale Cancer Center shared a post on LinkedIn: “For international medical professionals, Yale Cancer Center…
Apr 4, 2025, 11:03 | Drugs
Sotorasib (Lumakras): Uses in Cancer: Side effects: Dosage: Expectation and more
Sotorasib is a groundbreaking KRAS G12C inhibitor and the first targeted therapy for this mutation.…
Apr 3, 2025, 20:19 | Blog
Childhood Cancer International Calls for Support to Fund Life-Saving Treatment in Kenya
Childhood Cancer International shared a post on LinkedIn: "Cancer treatment isn’t guaranteed for all children.…
Apr 3, 2025, 12:43 | Drugs
How Much Does it Cost to Approve a Drug? EMA vs. FDA Regulations and Timelines
Cancer treatments are among the most groundbreaking and urgently needed medical advancements today. However, behind…
Apr 3, 2025, 09:29 | Science
Yan Leyfman: Ammonia - A Hidden Obstacle in Cancer Immunotherapy
Yan Leyfman, Co-founder and executive director of MedNews Week, shared an article by Joanna Domagala, et al.…
Apr 3, 2025, 08:53 | Drugs
Tian Zhang and Petros Grivas discussed best practices for Metastatic Urothelial Carcinoma Therapy
Tian Zhang, Associate Director of Clinical Research at Simmons Comprehensive Cancer Center and Director of…
Apr 3, 2025, 04:43 | Insight
Can engineered bacteria revolutionize cancer treatment? - Cancer Research Institute
Cancer Research Institute (CRI) shared a post on LinkedIn: "Can engineered bacteria revolutionize cancer treatment?…
Apr 1, 2025, 18:37 | Blog
Binay Shah: Three Timely Levers to help bridge growing gap in Cancer Care
Binay Shah, President at Binaytara, shared a post on LinkedIn: "Despite unprecedented advances in cancer…
Apr 1, 2025, 08:18 | Insight
Clinical Mondays: An Exciting Approach Towards Cancer Treatment - The Babak Lab
The Babak Lab shared a post on LinkedIn: "Clinical Mondays: An Exciting Approach Towards Cancer…
Mar 31, 2025, 10:38 | Insight
Rasha Aboelhassan: It's truly wonderful to discover new skills in yourself
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn about a recent…
Mar 31, 2025, 09:48 | Blog
Hadieh Eslampanah: Norouz reminds us of renewal, generosity, and strengthening our connections
Hadieh Eslampanah, Director of International Development and Communications Department at MAHAK Pediatric Cancer Treatment and…
Mar 30, 2025, 15:41 | Blog
New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
NCI Division of Cancer Control and Population Sciences shared a post on LinkedIn: "New Funding…
Mar 30, 2025, 14:01 | Cancer Types
Melanoma (Skin Cancer): Symptoms, Causes, Stages, Diagnosis and Treatment
Skin cancer is one of the most common forms of cancer worldwide, with melanoma being…
Mar 29, 2025, 20:20 | Blog
Benjamin L. Ebert: We know the importance and impact of having access to the best cancer treatment
Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared Dana-Farber Cancer Institute's post…
Mar 29, 2025, 18:03 | Blog
Marina Puchinskaya: It was an incredible lecture from ELCC 25
Marina Puchinskaya, Oncologist at "Kravira" Medical Centre, shared ESMO's post on LinkedIn: "It was an…
Mar 29, 2025, 17:00 | Blog
Antonio Passaro: What a time to be in thoracic oncology
Antonio Passaro, Medical Director at IEO European Institute of Oncology, shared on LinkedIn: "What a…
Mar 29, 2025, 06:23 | Blog
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Union for International Cancer Control (UICC) posted on LinkedIn: "Antimicrobial Resistance (AMR) is a growing…
Mar 28, 2025, 11:49 | Blog
I Central Asian Forum on Lung Cancer: Current Issues in Diagnosis and Treatment of Lung Cancer
Kazakhstan Cancer Society invites you to participate in the International Conference “I Central Asian Forum…
Mar 28, 2025, 10:50 | Blog
Julia's Brave Battle Against Leukemia: A Story of Hope and Progress - St. Baldrick's Foundation
St. Baldrick's Foundation posted on LinkedIn: "Six-year-old Julia’s bright smile can light up any room.…
Mar 27, 2025, 13:34 | Blog
Dennis Slamon and Sujuan Ba on HER2 Cancers - NFCR
National Foundation for Cancer Research (NFCR) shared a post on LinkedIn: "In Episode 3 of…
Mar 27, 2025, 12:41 | Blog
Understanding Lung Cancer Clinical Trials: Free Webinar This Friday - Lung Cancer Europe
Lung Cancer Europe shared on LinkedIn: "Reminder: Understanding Lung Cancer Clinical Trials - Free Webinar…
Mar 27, 2025, 07:38 | Drugs
Tucatinib (Tukysa): What patients need to know?
Tucatinib (brand name Tukysa) is a targeted cancer drug used to treat HER2-positive metastatic breast…
Mar 27, 2025, 05:04 | Drugs
Tucatinib (Tukysa): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Tucatinib is an oral tyrosine kinase inhibitor (TKI) that selectively inhibits HER2, a receptor tyrosine…
Mar 26, 2025, 17:16 | Blog
Peter Pisters: MD Anderson Cancer Center Volunteers Use Art to Empower Patients During Treatment
Peter Pisters, President of MD Anderson Cancer Center, shared a post on X: "Our MD…
Mar 26, 2025, 08:55 | Blog
Amol Akhade: Why should oncologists who are not into Academic institutions publish scientific papers?
Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…
Mar 25, 2025, 09:09 | Blog
The 2025 Survivorship Conference on April 12 is fast approaching - Masonic Cancer Center
Masonic Cancer Center, University of Minnesota shared on LinkedIn: "The 2025 Survivorship Conference on April…
Mar 24, 2025, 09:05 | Blog
David Planchard: Neoadjuvant and adjuvant treatments for lung cancer to optimize patients' survival
David Planchard, Thoracic Oncologist and Professor at the University Paris Saclay, posted on LinkedIn: "So…
Mar 24, 2025, 08:15 | Blog
How COMBINE and ACT EU projects are transforming clinical research ecosystems - EORTC
EORTC - European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:…
Mar 23, 2025, 15:21 | Drugs
Elacestrant: What patients need to know?
Elacestrant (brand name Orserdu) is a breakthrough oral medication for treating advanced or metastatic estrogen…
Mar 23, 2025, 14:33 | Drugs
Elacestrant (Orserdu): Uses in Cancer: Side effects: Dosage: Expectations, and More
Elacestrant is an oral selective estrogen receptor degrader (SERD) used to treat advanced or metastatic…
Mar 22, 2025, 07:12 | Science
Jennifer Bires: Fertility Preservation in People with Cancer
Jennifer Bires, Executive Director of Life with Cancer and Patient Experience for the Inova Schar…
Mar 18, 2025, 06:38 | Blog
Cristiane D Bergerot: April 9 will be celebrated as World Psycho-Oncology Day
Cristiane D Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared on…
Mar 15, 2025, 04:58 | Blog
Aaron Sverdlov: HMRI Australia’s first community information event on cardio-oncology
Aaron Sverdlov, Professor and Director of Heart Failure and Co-Director at Newcastle Centre of Excellence…
Mar 14, 2025, 13:13 | Drugs
Enfortumab Vedotin (Padcev): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Enfortumab Vedotin, also known as Padcev, is a groundbreaking antibody-drug conjugate (ADC) designed to target…
Mar 13, 2025, 15:52 | Oncolibrary
New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer
Immune Checkpoint Inhibitor-Associated Toxicities are still a huge obstacle for patients, especially for older adults.…
Mar 13, 2025, 14:28 | Blog
Judy Medeiros Fitzgerald: Why cancer patients dislike labels like "survivor" and "warrior"
"General Definition of Survivor: a person who survives, especially a person remaining alive after an…
Mar 11, 2025, 16:02 | Oncolibrary
VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer
Phase 3 VERITAC-2 trial (NCT05654623) results were announced by Arvinas and Pfizer.  evaluating vepdegestrant, an…
Mar 11, 2025, 10:45 | Oncolibrary
New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer
The HARMONi-2 study, a randomized phase 3 trial conducted in China, compared ivonescimab with pembrolizumab…
Mar 9, 2025, 12:54 | Radiotherapy
Radiotherapy for Rectal Cancer: Types, Success Rate, Side Effects And More
Radiotherapy for rectal cancer is a key treatment option that uses high-energy radiation to target…
Mar 7, 2025, 10:36 | Blog
One of the biggest challenges in cancer treatment, the overwhelming complexity of tumor genetics - Genomate Health
Genomate Health shared a post on LinkedIn: "At Ci4CC CIGR 2025, Dr. Istvan Petak will…
Mar 7, 2025, 01:18 | Immune Oncology
Immunotherapy for Brain Cancer: Types, Success Rate, Side Effects and More
Brain cancer, particularly aggressive forms like glioblastoma, remains one of the most challenging malignancies to…
All: 870 Posts: 1 - 100
Special Coverage